Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 09-2015 | 06-2015 | 12-2014 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -29,810 | -19,129 | -10,665 | -13,430 |
| Depreciation Amortization | 600 | 373 | 184 | 250 |
| Accounts payable and accrued liabilities | N/A | 721 | 285 | N/A |
| Other Working Capital | 2,930 | 1,542 | -8 | 260 |
| Other Operating Activity | 3,250 | 1,664 | 839 | 960 |
| Operating Cash Flow | $-23,030 | $-14,829 | $-9,365 | $-11,960 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,170 | -883 | -171 | -200 |
| Investing Cash Flow | $-1,170 | $-883 | $-171 | $-200 |
| Cash Flows From Financing Activities | ||||
| Debt Repayment | N/A | -32 | -16 | N/A |
| Common Stock Issued | N/A | 336 | 336 | N/A |
| Other Financing Activity | -270 | 0 | 0 | 68,760 |
| Financing Cash Flow | $-270 | $304 | $320 | $68,760 |
| Beginning Cash Position | 60,390 | 60,393 | 60,393 | 3,800 |
| End Cash Position | 35,900 | 44,985 | 51,177 | 60,390 |
| Net Cash Flow | $-24,480 | $-15,408 | $-9,216 | $56,590 |
| Free Cash Flow | ||||
| Operating Cash Flow | -23,030 | -14,829 | -9,365 | -11,960 |
| Capital Expenditure | N/A | -883 | -171 | N/A |
| Free Cash Flow | -23,030 | -15,712 | -9,536 | -11,960 |